Skip to main content

Table 1 Revised baseline characteristics of patients between EPO group and ioversol group

From: Ethiodized poppyseed oil versus ioversol for image quality and adverse events in hysterosalpingography: a prospective cohort study

Parameters

EPO group (N = 165)

Ioversol group (N = 63)

P Value

Age (years)

31.36 ± 4.99

31.40 ± 4.64

0.960

BMI (kg/m2)

22.79 ± 6.11

21.97 ± 4.07

0.319

History of smoke (n/%)

14 (8.5)

6 (9.5)

0.804

Current smoker (n/%)

3 (1.8)

1 (1.6)

0.905

History of sex life (years)

7.0 (4.0–10.0)

7.0 (4.0–10.5)

0.763

Childbearing history

  

0.519

 None (n/%)

106 (64.2)

36 (57.1)

 

 Once (n/%)

44 (26.7)

17 (27.0)

 

 Twice (n/%)

10 (6.1)

6 (9.5)

 

  ≥ 3 times (n/%)

5 (3.0)

4 (6.4)

 

 Times of abortion

  

0.531

 None (n/%)

78 (47.3)

30 (47.6)

 

 Once (n/%)

35 (21.2)

18 (28.6)

 

 Twice (n/%)

29 (17.6)

8 (12.7)

 

  ≥ 3 times (n/%)

23 (13.9)

7 (11.1)

 

The interval between last abortion and the present examination (months)

46.0 (23.0–81.0)

45.5 (12.0–63.3)

0.291

The way of last abortion

  

0.774

 Accidental abortion (n/%)

3 (1.8)

3 (4.8)

 

 Induced by drugs (n/%)

19 (11.5)

5 (7.9)

 

 Artificial abortion (n/%)

60 (36.4)

22 (34.9)

 

 Painless induced abortion (n/%)

3 (1.8)

2 (3.2)

 

 Induced labour (n/%)

2 (1.2)

1 (1.6)

 

Duration of infertility (years)

2.0 (1.0–4.0)

2.0 (1.5–4.0)

0.447

Spontaneous menstrual cycle (n/%)

149 (90.3)

59 (93.7)

0.427

Regular menstrual cycle (n/%)

140 (84.4)

56 (88.9)

0.432

Menstrual cycle (days)

29.0 (28.0–31.0)

30.0 (28.0–33.0)

0.088

Sexual behavior in menstruation

  

0.259

 Never (n/%)

140 (84.8)

48 (76.2)

 

 Occasional (n/%)

20 (12.1)

13 (20.6)

 

 Often (n/%)

5 (3.0)

2 (3.2)

 

Bath in menstruation

  

0.651

 Never (n/%)

135 (81.8)

49 (77.8)

 

 Occasional (n/%)

26 (15.8)

13 (20.6)

 

 Often (n/%)

4 (2.4)

1 (1.6)

 

Endocrine disorder (n/%)

12 (7.3)

3 (4.8)

0.700

Endometritis

  

0.923

 Yes (n/%)

11 (6.7)

4 (6.3)

 

 No (n/%)

150 (90.9)

58 (92.1)

 

 Unknown (n/%)

4 (2.1)

1 (1.6)

 

Previous chlamydia infection

  

0.209

 Yes (n/%)

16 (9.7)

3 (4.8)

 

 No (n/%)

145 (87.9)

60 (95.2)

 

 Unknown (n/%)

4 (2.4)

0 (0.0)

 

Pelvic inflammatory disease

  

0.370

 Yes (n/%)

86 (52.1)

33 (52.4)

 

 No (n/%)

74 (44.8)

30 (47.6)

 

 Unknown (n/%)

5 (3.0)

0 (0.0)

 

Coleitis

  

0.258

 Yes (n/%)

87 (52.7)

39 (61.9)

 

 No (n/%)

74 (44.8)

24 (38.1)

 

 Unknown (n/%)

4 (2.4)

0 (0.0)

 

Follicular estrogens

  

0.009

 Normal (n/%)

135 (81.8)

61 (96.8)

 

 Abnormal (n/%)

11 (6.7)

2 (3.2)

 

 Unknown (n/%)

19 (11.5)

0 (0.0)

 

Tuberculosis of uterus/tubal

  

0.650

 Yes (n/%)

5 (3.0)

1 (1.6)

 

 No (n/%)

159 (96.4)

61 (96.8)

 

 Unknown (n/%)

1 (0.6)

1 (1.6)

 

Previous surgery

  

0.673

 Hysteroscopy (n/%)

12 (7.3)

8 (12.7)

 

 Laparoscope (n/%)

12 (7.3)

4 (6.3)

 

 Cesarean section (n/%)

12 (7.3)

2 (3.2)

 

 Tubal surgery (n/%)

6 (3.6)

2 (3.2)

 

 Ectopic pregnancy surgery (n/%)

6 (3.6)

1 (1.6)

 

 Others (n/%)

30 (18.2)

8 (12.7)

 
  1. Data was presented as mean value±standard deviation, median (quartile 25th–75th) or count (%). Comparison was determined by t test, Wilcoxon rank sum test or Chi-square test
  2. EPO ethiodized poppyseed oil, BMI body mass index
  3. P value in boldface stood for statistical significant